Ellington Management Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,777
Closed -$243K 151
2020
Q1
$243K Buy
+4,777
New +$275K 0.06% 379
2019
Q4
Sell
-6,034
Closed -$304K 580
2019
Q3
$304K Buy
+6,034
New +$303K 0.06% 367
2018
Q4
Sell
-9,553
Closed -$592K 455
2018
Q3
$592K Buy
+9,553
New +$581K 0.16% 175
2018
Q2
Sell
-19,735
Closed -$898K 590
2018
Q1
$898K Buy
+19,735
New +$846K 0.06% 226
2017
Q4
Sell
-12,696
Closed -$468K 652
2017
Q3
$468K Buy
+12,696
New +$452K 0.08% 234
2014
Q3
Sell
-12,444
Closed -$355K 335
2014
Q2
$355K Buy
+12,444
New +$347K 0.17% 183
2013
Q3
Sell
-20,741
Closed -$475K 817
2013
Q2
$475K Buy
+20,741
New +$469K 0.09% 330

Other funds holding EHC

Ellington Management Group's EHC Position: Q2 2020 in Review

Ellington Management Group sold out of Encompass Health (EHC) in Q2 2020, closing a stake of 4,777 shares — an estimated $243K sold.

Ellington Management Group first reported a position in EHC in Q2 2013 and held it in 7 quarters. The position peaked at $898K in Q1 2018. 384 funds tracked by Wall St. Rank hold EHC as of Q2 2020.

  • Ellington Management Group reported no remaining Encompass Health position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 4,777 Encompass Health shares in Q2 2020, an estimated $243K.
  • Ellington Management Group first reported a position in Encompass Health in Q2 2013 and held it in 7 quarters.
  • Ellington Management Group's Encompass Health position peaked at $898K in Q1 2018.
  • 384 funds tracked by Wall St. Rank held Encompass Health as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.